Stock Signal Information
Signal
Analyst Upgrade Stock
Report Date: 05-05-2022
Symbol: ESPR - Esperion Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Analyst Upgrade Signal: ESPR from Underweight to Neutral by JP Morgan
Price Target: $6
Company Contact
Esperion Therapeutics, Inc. (ESPR)
3891 Ranchero Dr Ste 150
Ann Arbor, MICHIGAN 48108
Phone: 17348873903
Website: http://www.esperion.com
CEO: Mr. Timothy Mayleben
Company Profile
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was founded in 2008 and is headquartered in Ann Arbor, Michigan.
stock trading signals, free stock signals, stock option trading signals, stock trading signals
About Top Stock Signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228
Stock Trading FAQs
How do I build a diversified stock portfolio?What are the tax implications of stock trading?What are the different types of stock orders (market orders, limit orders, stop-loss orders, etc.)?What are the common mistakes to avoid in stock trading?What are stock market circuits and how do they affect trading?A.I. in Stock and Option Trading FAQsStock Trading FAQsOptions Trading FAQs